Heyman Irwin A 4
4 · Anacor Pharmaceuticals Inc · Filed Mar 14, 2012
Insider Transaction Report
Form 4
Heyman Irwin A
Senior VP Product Development
Transactions
- Award
Stock Option (right to buy)
2012-03-13+40,000→ 40,000 totalExercise: $5.59Exp: 2022-03-12→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest and become exercisable on the twelve-month anniversary of the Vesting Commencement Date (1/1/2012) and 1/48 of the shares subject to the option shall vest and become exercisable each month thereafter.